The Effectiveness of Intravitreal Avastin Injection for CRVO

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01678248

Enrollment

Registered

2012-09-03

Start date

2006-01-31

Completion date

Unknown

Last updated

2012-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Retinal Vein Occlusion

Brief summary

to determine the effectivness of intravitreal avastin injection on visual acuity on people that suffer from central retinal vein occlusion

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients above 18 years old * suffer from CRVO * maximal visual acuity 6/15

Exclusion criteria

* VA of LP * retinal disease other than CRVO * incomplete medical record * follow up less than 6 months

Countries

Israel

Contacts

Primary ContactJoseph pikkel, M.D

pikel.y@ziv.health.gov.il972508434206

Backup ContactOtzem Chassid, M.D

otzem.c@ziv.health.gov.il972506266059

Outcome results